極低出生体重児に対するビフィズス菌サプリメント

基本情報

NCT ID: NCT01375309
ステータス: 完了
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 246
治験依頼者名: Tokyo Women's Medical University

概要

Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm infants who received Bifidobacterium bifidum early after birth. In order to evaluate these beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to preterm infants improve enteral feeding and growth in very low birth weight infants.

対象疾患

Preterm Infants

介入

Bifidobacterium bifidum supplementation(DIETARY_SUPPLEMENT)

Placebo contains dextrin(DIETARY_SUPPLEMENT)

依頼者（Sponsor）

Tokyo Women's Medical University(OTHER)

実施施設 (1)

東京女子医科大学病院

Shinjuku, Tokyo, Japan